#medical-devices
(8 articles)Stryker Q2: Supply Chain Woes Offset Margin Gains
Stryker Corporation's second quarter results reveal a critical tension in the current supply chain landscape: while the medical device manufacturer achieved meaningful margin expansion through operati
IEEPA Tariff Refunds for Medtech: What Companies Need Know
The U.S. International Emergency Economic Powers Act (IEEPA) tariff refund program is opening opportunities for the medical technology sector to recover duties paid on affected imports. This announcem
Boston Scientific Cyberattack Disrupts Orders and Shipping
Boston Scientific, a major medical device manufacturer, has disclosed a significant cyberattack that has disrupted its ordering and shipping operations across global facilities. The attack's full scop
Boston Scientific Cyberattack Disrupts Orders, Shipping Operations
Boston Scientific, a major global medical device manufacturer, experienced a significant cyberattack that disrupted both its ordering and shipping operations. This incident represents a critical vulne
Citizens Cuts Stryker Stock Target Amid Supply Chain Woes
Citizens Investment Research has reduced its stock price target for Stryker Corporation, citing ongoing supply chain disruptions impacting the medical device manufacturer's operations and financial pe
Stryker Stock Target Cut Over Supply Chain Disruptions
Citizens Securities has reduced its stock price target for Stryker Corporation, a major medical device manufacturer, citing persistent supply chain disruptions affecting production and delivery capabi
Stryker Q2: Margin Gains Offset by Supply Chain Headwinds
Stryker Corporation's second-quarter financial results reveal a mixed operational landscape: while the company achieved margin expansion through improved pricing and cost management, persistent supply
FedEx Creates Dedicated Life Sciences Unit for Pharma Logistics
FedEx announced the establishment of FedEx Life Sciences, a standalone organization dedicated to managing the complex logistics needs of the pharmaceutical, medical device, and biologics sectors. The